Atlas Trials

Phase 1 Study of BCD-245 in Subjects With Neuroblastoma

Clinical trial NCT05782959 · UNKNOWN

Trial details

NCT number
NCT05782959
Sponsor
Biocad
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroblastoma
Start date
2021-11-29
Primary completion
2023-06-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.